Clinical Chemistry Market

Growing Demand for Clinical Chemistry Test Kits to Boost Market

Several major changes in the clinical chemistry market have been brought about as a result of the convergence of system automation, engineering and IT technology. Technological advancements in the clinical chemistry market have created numerous opportunities for various new reagents, instruments, calibrators and several other related clinical chemistry products.

For instance, the StaRRsed Inversa automated Erythrocyte Sedimentation Rate (ESR) analyzer helps lower the possibility of the manual errors that occur during any clinical chemistry analytical procedure. In January 2017, Roche launched cobas m 511, an integrated haematology analyzer. This analyzer combines the three components of the process: a cell counter, digital morphology analyzer and classifier, into 1 streamlined solution that helps prepare, analyze and stain microscopy blood slides.

Constant developments in clinical chemistry devices have resulted in enhancing the product portfolio of manufacturers as well as improving the efficacy of test results. Advancements in the expansion of clinical chemistry testing menus & instrument capabilities, immunoassay instruments and reagent adaptables to core laboratory workstations is also projected to contribute to the growth of the clinical chemistry market over the forecast period.

Shift Towards Built-in Quality Assurance Automated Devices/Analyzers

In the present scenario, healthcare settings, majorly hospitals, are significantly inclined towards owning fully-automated clinical chemistry systems that have built-in quality-assurance capabilities. These clinical chemistry systems possess the ability to process a larger number of samples at a time.

For instance, these fully-automated clinical chemistry systems are capable of performing functions such as tube sampling, the recognition of a sample & reagent bottles, cap piercing, dilution and automatic re-run.

There is also an increase in the number of government initiatives that aim at promoting better healthcare diagnostic facilities to provide quicker results, which has further contributed to the shift toward these automated devices. This shift is one of the major factors contributing to the growth of clinical chemistry market.

Strong Penetration of POCT Kits and Analyzers in Lifestyle Related Disorders

Point of care testing is important for the rapid detection of the analytes close to the patient for better diagnosis, management and monitoring. It enables the detection of diseases at an early stage. A wide range of point-of-care assays for the quantitative determination of biomarkers is being developed with the use of easy-to-use and portable POC biochemical and clinical analyzers.

Lifestyle-related diseases, such as cardiovascular diseases, have been a global threat and are majorly responsible for the high mortality rates worldwide. Lifestyle diseases, such as diabetes mellitus, hypertension, overweight/obesity and dyslipidaemia, are among the major risk factors that can lead to the development of cardiovascular diseases.

According to the National Center for Biotechnology Information, cardiovascular diseases are considered to be a major cause of mortality, which represents approximately 30% of all the deaths worldwide.

Lack of Skilled Professionals Likely to Hamper Market Growth

The role of laboratory-based physicians or clinical pathologists is consistently being challenged on various fronts, such as, increasing the patient autonomy exercised for direct testing, exponential advancements in clinical chemistry technology and the usage of non-medical specialists as substitutes.

The lack of skilled professionals for various clinical chemistry processes is likely to hamper the growth of the clinical chemistry market during the forecast period. For instance, countries in the SADC, which is the Southern Africa Development Community, are facing a severe scarcity of laboratory pathologists.

The number of pathologists in this region for the examination of samples or interpretation of clinical chemistry laboratory tests for ensuring proper patient treatment is low, which is likely to affect disease diagnosis and the treatment of various diseases in the region.

Competitive Landscape

The competition section of the clinical chemistry market report features the profiles of the key players operating in the clinical chemistry market based on their differential strategies, market shares, product offerings, company dashboard and marketing approach.

Examples of some of the key players operating in the clinical chemistry market are Siemens AG, Abbott, Thermo Fischer Scientific, Danaher, F. Hoffmann-La Roche Ltd., bioMérieux SA, Bio-Rad Laboratories Inc., Cardinal Health, Inc., Mindray Medical International Limited and Hitachi, Ltd.

Definition

Clinical chemistry utilises chemical processes for measuring certain levels of chemical components in an individual’s body fluid. The common specimens that are tested in clinical chemistry are urine, blood and cerebrospinal fluid.

There are various clinical chemistry tests that exist to test these chemical components in the urine or blood, which include electrolytes, blood glucose, hormones, enzymes, proteins, lipids (fats) and other metabolic substances.

About the Report

PMR conducted a research study on the clinical chemistry market for the forecast period 2017 to 2026. The clinical chemistry report offers a comprehensive evaluation of the business opportunities prevailing in the clinical chemistry market, along with insights on the clinical chemistry market evolution, market trends, product feature comparison, the brand share analysis of the clinical chemistry analysers, pricing analysis based on product type and clinical chemistry market competition. The report elaborates the macro-economic factors influencing the dynamics of the market and its futuristic potential.

Segmentation

The report offers a comprehensive taxonomy of the clinical chemistry market based on the product type, end users and region. The clinical chemistry market by product type is segmented into clinical chemistry analysers, POC test kits and clinical chemistry analyser kits & reagents.

The clinical chemistry analysers are further sub-segmented into semi-automated clinical chemistry analysers and automated clinical chemistry analysers. By POC test kits, the clinical chemistry market is sub-segmented into test strips, cassettes and dipsticks. The end user segment of the clinical chemistry is segmented into hospitals, pathology laboratories, maternity centres, outpatient centres and clinics.

The clinical chemistry market has been analysed across all the regions of North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa.

Additional Questions Answered

Some of the additional questions addressed in this report on the clinical chemistry market-

• What is the revenue potential of the clinical chemistry market across the regions of North America and Europe?
• Who are the key competitors and what are their portfolios in the clinical chemistry market?
• What are the major challenges influencing the growth of the clinical chemistry market?
• How is the intervention of regulatory authorities shaping the growth of the clinical chemistry market?